Myelodysplastic Syndromes (MDS): Caring for Low and High-Risk Patients

James M. Foran, MD, FRCPC, Mayo Clinic Cancer Center, Jacksonville, FL

Recorded on May 28, 2020

Listen in as Dr. James Foran from Mayo Clinic defines MDS, discusses the diagnostic workup and factors used to develop a treatment plan, including the importance of the morphology of the bone marrow and the blast count, cytogenetics and next generation sequencing and patient management strategies for low and high-risk MDS. The conversation continues with potentially exciting treatment options being studied in clinical trials, the impact of COVID-19 on caring for patients with MDS, and the involvement of the entire healthcare team.
James M. Foran, MD, FRCPC
James M. Foran, MD, FRCPC
Consultant & Associate Professor
Division of Hematology & Medical Oncology
Mayo Clinic Cancer Center
Jacksonville, FL

Leave a Reply

Your email address will not be published. Required fields are marked *